Archives

by in
Entry Author Date Location
Famed Geneticist Altshuler Bolts Broad Institute for Vertex 12/15/14 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
Phytonix Turns Photosynthetic Bacteria Into Tiny Chemical Factories 12/15/14 Raleigh Durham
Big Events, Exits Raising Boston’s Innovation Profile at Year’s End 12/12/14 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Pioneer’s Lament: Lack of Checkpoint Immunotherapy For Blood Cancer 12/08/14 National
Bluebird 4 For 4 As Gene Therapy Helps More Blood Disease Patients 12/08/14 Boston
Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk 12/08/14 National
Boston Heart Diagnostics Bought by Eurofins for $140M 12/08/14 Boston
Independent No More: Cubist Sold to Merck for $9.5B 12/08/14 Boston
At ASH, Sunesis Dices Data to Argue For “Failed” Leukemia Drug 12/07/14 San Francisco
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
Xfund Closes $100M Fund as Venture Firms and Universities Get Cozier 12/04/14 Boston
Fast-Growing Maxwell Nets $26M More to Manage Your Healthcare 12/04/14 Boston
With Crossover Cash, Seres Health Aims For Big Microbiome Milestones 12/02/14 Boston
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” 12/02/14 National
With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy 12/01/14 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
The Healthcare Summit 2014: The Photos 11/25/14 Boston
BioMarin Gambles $840M on Prosensa’s Duchenne Drug 11/24/14 San Francisco
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
Symbiota Maps Plant Microbiome to Boost Crop Yields 11/24/14 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Seattle’s Fred Hutch Taps a Harvard, Merck Vet As New President 11/20/14 Seattle
CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma 11/19/14 Boston
Déjà Vu for Agios as Second Drug Shines in Small Blood Cancer Study 11/18/14 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
Celldex Touts Brain Cancer Vaccine Data, Talks FDA Strategy 11/14/14 New York
Page 2 of 90 « previous page · next page »